Oral Typhoid Vaccine Market

Oral Typhoid Vaccine Market, By Vaccine Type (Live Attenuated Vaccine, Inactivated Vaccine), By Age Group (Pediatric Vaccines, Adult Vaccines), By Distribution Channel (Hospitals and Clinics, Pharmacies and Retail Outlets, Government Immunization Programs), By End-User (Travelers, Residents of Endemic Areas, Healthcare Workers), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health concern, particularly in developing countries. With over 10 million cases reported each year, it is crucial to explore effective preventive measures, one of which is the oral typhoid vaccine

The oral typhoid vaccine, also known as Ty21a, has gained popularity due to its convenience and effectiveness in preventing typhoid fever. Unlike traditional injectable vaccines, this innovative vaccine is administered orally, making it easier to distribute and administer, especially in areas with limited healthcare facilities.

Market Dynamics:

The oral typhoid vaccine market is driven by several factors. Firstly, the increasing global incidence of typhoid fever has created a need for effective preventive measures, thereby boosting the demand for oral typhoid vaccines. Additionally, the growing awareness about the benefits of vaccination and the importance of public health initiatives has contributed to market growth.

However, there are also certain restraints to the market. One such challenge is the limited access to healthcare services in many regions, hindering the distribution and administration of oral typhoid vaccines. Moreover, the high cost associated with vaccine production and distribution poses a barrier to reaching underserved populations.

Despite these challenges, the oral typhoid vaccine market holds promising opportunities for growth. The development of cost-effective manufacturing processes and streamlined distribution networks can help overcome access barriers. Furthermore, ongoing research and development efforts to enhance the efficacy and safety of oral typhoid vaccines can drive market expansion.

Key features of the study:
  • This report provides in-depth analysis of the global oral typhoid vaccine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oral typhoid vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Oral Typhoid Vaccine market include Sanofi Pasteur, Bharat Biotech, Pfizer Inc., and GlaxoSmithKline (GSK), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global oral typhoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral typhoid vaccine market
Detailed Segmentation:
  • By Vaccine Type:
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • By Age Group:
  • Pediatric Vaccines
  • Adult Vaccines
  • By Distribution Channel:
  • Hospitals and Clinics
  • Pharmacies and Retail Outlets
  • Government Immunization Programs
  • By End-User:
  • Travelers
  • Residents of Endemic Areas
  • Healthcare Workers
  • By Geographic Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Top companies in Oral Typhoid Vaccine Market:
  • Sanofi Pasteur
  • Bharat Biotech
  • Pfizer Inc.
  • GlaxoSmithKline (GSK)
  • Baxter International Inc.
  • Merck & Co., Inc. (MSD outside North America)
  • Takeda Pharmaceutical Company Limited
  • Novartis International AG
  • Biological E. Limited
  • AstraZeneca
  • Cipla Limited
  • Prokarium
  • Bio-Med Pvt. Ltd.
  • Panacea Biotec
  • Dynavax Technologies Corporation
  • Butantan Institute
  • Zydus Cadila
  • Biomed Pvt. Ltd.
  • Cadila Healthcare Limited
  • GlaxoSmithKline Biologicals


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Oral Typhoid Vaccine, By Vaccine Type
Market Oral Typhoid Vaccine, By Age Group
Market Oral Typhoid Vaccine, By Distribution Channel
Market Oral Typhoid Vaccine, By End-User
Market Oral Typhoid Vaccine, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Growing awareness about the benefits of vaccination
Limited Access in Low-Income Regions
Expanding immunization programs in developing countries
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Oral Typhoid Vaccine Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Oral Typhoid Vaccine Market , By Vaccine Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Live Attenuated Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Inactivated Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Oral Typhoid Vaccine Market , By Age Group, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Pediatric Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Adult Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Oral Typhoid Vaccine Market , By Distribution Channel, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Pharmacies and Retail Outlets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Government Immunization Programs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Oral Typhoid Vaccine Market , By End-User, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Travelers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Residents of Endemic Areas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Healthcare Workers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Oral Typhoid Vaccine Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
10. Competitive Landscape
Sanofi Pasteur
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bharat Biotech
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline (GSK)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Baxter International Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc. (MSD outside North America)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis International AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Biological E. Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Others
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Oral Typhoid Vaccine Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings